MEDGENICS INC has a total of 59 patent applications. Its first patent ever was published in 2002. It filed its patents most often in EPO (European Patent Office), Israel and Australia. Its main competitors in its focus markets medical technology, pharmaceuticals and biotechnology are FUNDACION PARA LA INVESTIG BIOMEDICA DEL HOSPITAL GREGORIO MARANON, CHARLOTTE MECKLENBURG HOSPITAL and ROBARTS RES INST.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 9 | |
#2 | Israel | 8 | |
#3 | Australia | 7 | |
#4 | Republic of Korea | 7 | |
#5 | Canada | 6 | |
#6 | Japan | 6 | |
#7 | WIPO (World Intellectual Property Organization) | 5 | |
#8 | China | 4 | |
#9 | Hong Kong | 4 | |
#10 | Brazil | 1 | |
#11 | Mexico | 1 | |
#12 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Medical technology | |
#2 | Pharmaceuticals | |
#3 | Biotechnology | |
#4 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Diagnosis and surgery | |
#3 | Therapeutic chemical compounds | |
#4 | Microorganisms | |
#5 | Implantable devices | |
#6 | Unspecified technologies | |
#7 | Syringes | |
#8 | Microbiology |
# | Name | Total Patents |
---|---|---|
#1 | Pearlman Andrew L | 49 |
#2 | Bellomo Stephen F | 47 |
#3 | Shavitt Menachem D | 46 |
#4 | Lippin Itzhak | 46 |
#5 | Rosenberg Lior | 46 |
#6 | Bukhman Mordechay | 44 |
#7 | Stern Baruch S | 30 |
#8 | Almon Einat | 30 |
#9 | Piva Guillermo Alberto | 29 |
#10 | Shalhevet David | 29 |
Publication | Filing date | Title |
---|---|---|
IL206316A | Closed automated system for tissue based therapy, dosing and administration using same | |
IL161746A | Closed automated system for tissue based therapy, dosing and administration using same | |
CN102816738A | Dermal micro-organs, methods and apparatuses for producing and using the same | |
US7468242B2 | Dermal micro organs, methods and apparatuses for producing and using the same | |
EP1451571A2 | Devices for dosing and administration of therapeutic micro-organs in living subjects | |
AU2002317458A1 | Efficient methods for assessing and validating candidate protein-based therapeutic molecules encoded by nucleic acid sequences of interest |